METRA Drug Patent Profile
✉ Email this page to a colleague
When do Metra patents expire, and what generic alternatives are available?
Metra is a drug marketed by Forest Pharms and is included in one NDA.
The generic ingredient in METRA is phendimetrazine tartrate. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Metra
A generic version of METRA was approved as phendimetrazine tartrate by VIRTUS on December 31st, 1969.
Summary for METRA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 21 |
Patent Applications: | 1,902 |
Formulation / Manufacturing: | see details |
DailyMed Link: | METRA at DailyMed |
US Patents and Regulatory Information for METRA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Forest Pharms | METRA | phendimetrazine tartrate | TABLET;ORAL | 083754-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |